Hims & Hers shares tumble 18% as margin miss adds to concerns about GLP-1 business

Hims & Hers shares tumble 18% as margin miss adds to concerns about GLP-1 business


The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New York City.

Carlo Allegri | Reuters

Hims & Hers Health shares plunged 18% in extended trading on Monday after investors looked past better-than-expected revenue and earnings and focused instead on the disappointing gross margin.

Here’s how the company did, compared to analysts’ consensus estimates from LSEG:

  • Earnings per share: 11 cents vs. 10 cents expected
  • Revenue: $481 million vs. $470 million expected

Revenue at the telehealth company increased 95% in the fourth quarter from $246.6 million during the same period last year, according to a release.

However, the company’s gross margin, or the profit left after accounting for the cost of goods sold, was 77%, while analysts polled by StreetAccount were expecting 78.4%.

It’s the second big stock drop for Hims & Hers in a matter of days. The shares tumbled 26% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved.

In May, Hims & Hers started prescribing compounded semaglutide, the active ingredient in Novo Nordisk’s blockbuster GLP-1 medications Ozempic and Wegovy. The company was a breakout star within the digital health sector in 2024, in part because of the success of its popular new weight loss offering. The stock climbed about 200% for the year.

Compounded drugs are custom-made alternatives to brand-name drugs designed to meet a specific patient’s needs, and compounders are allowed to produce them when brand-name treatments are in shortage. The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days.

Hims & Hers also offers treatments for skin care, mental health, sexual health and hair care.

Excluding its GLP-1 offerings, revenue increased 43% to $1.2 billion for the full year, “meeting our previous 2025 revenue target a year early,” CFO Yemi Okupe said in a release.

“The success we are experiencing is a direct reflection of our improving ability to democratize access to high quality, personalized care across each of our specialties,” Okupe said.

Net income climbed to $26.01 million, or 11 cents per share, from $1.25 million, or 1 cent per share, a year prior. The company reported adjusted earnings of $54.1 million, meeting analyst estimates, according to StreetAccount.

For the first quarter, Hims & Hers expects to report revenue of $520 million to $540 million, while analysts were expecting $497 million. Adjusted earnings will be between $55 million to $65 million for the period, the company said.  

Hims & Hers will host its quarterly call with investors at 5:00 p.m. ET.

— CNBC’s Brandon Gomez contributed to this report.

Don’t miss these insights from CNBC PRO



Source

Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access
Health

Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A wave of outrage is sweeping the scientific and medical world after Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to stop recommending routine Covid-19 […]

Read More
CDC ends Covid vaccine recommendation for healthy kids and pregnant women
Health

CDC ends Covid vaccine recommendation for healthy kids and pregnant women

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and Secretary of Education Linda McMahon attend a Make America Healthy Again (MAHA) Commission event, in the East Room of the White House in Washington, D.C., U.S., May 22, 2025. Evelyn Hockstein | Reuters The Centers for Disease Control and Prevention will no longer […]

Read More
Ambience announces OpenAI-powered medical coding model that outperforms physicians
Health

Ambience announces OpenAI-powered medical coding model that outperforms physicians

Dr. Priti Patel, CMIO at John Muir Health, uses Ambience before starting a patient encounter. Courtesy of Ambience Healthcare Artificial intelligence startup Ambience Healthcare on Tuesday announced a new medical coding model that outperforms doctors by 27%. Ambience uses AI to draft clinical notes in real-time as doctors consensually record their visits with patients. The […]

Read More